November was Diabetes Awareness Month Diabetes affects millions of people. It is a major cause of peripheral neuropathy. Last month, we shared information to help you understand how diabetes develops. We explained why it can damage nerves, and what you can do to stay healthy. Learning the signs early and managing blood sugar can lower […]
Diabetes is the main cause of peripheral neuropathy. We’re supporting diabetes awareness month by promoting diabetes education. By learning about what can increase your risk of getting diabetes and the signs that show you might have it, you can take steps to prevent it or manage it better. And keeping your diabetes under control reduces […]
We are honored to share that on October 20, 2025, the Foundation for Peripheral Neuropathy (FPN) received the incredible gift of a substantial sum from our longtime supporter and friend, Lynne Warner. This generous donation, given in her memory, will have a lasting impact and bring hope to the peripheral neuropathy community. About Lynne Warner […]
Read More… from The Foundation for Peripheral Neuropathy Received Transformational Gift
Research update with Dr. Michelassi Francesco Michelassi, MD, PhD, Physician and Lead Scientist at the University of Virginia Health and the 2024 Clinical Research Training Scholarship (CRTS) recipient, shares his work studying Chemotherapy-Induced Peripheral Neuropathy (CIPN). He explains how his research could help protect nerves and lead to new treatments. Learn how FPN helped Dr. […]
Celebrating Jack Miller, FPN’s founder on FPN Day Tomorrow, FPN celebrates its 18th anniversary. In honor of our founding, we are proud to celebrate Jack Miller, the man who founded the Foundation for Peripheral Neuropathy. In his previous patient story from 2011, Jack shared the complete history of why he started FPN and his own long journey with peripheral neuropathy. […]
Chemotherapy induced peripheral neuropathy (CIPN) can impact up to 70% of chemo patients. The effects can linger long after chemotherapy has ended. Patients can be left with issues in their hands or feet ranging from pain and tingling to muscle weakness. Treating CIPN is really hard Scientists don’t fully understand what causes CIPN. Studies have shown that […]
Read More… from Chemotherapy induced peripheral neuropathy research is on the rise
We’re pleased to announce our newest board member, Jennie Starr. Starr started her career as a lawyer, then worked for both tech and biotech companies. She also ran a nonprofit while raising her children. Now she’s bringing all of that experience to help support our mission. About Jennie Starr Starr has always liked building new […]
Read More… from New Board Member Jennie Starr: A Builder with a Big Heart
The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Vertex Pharmaceuticals, as an esteemed 2025 Premier Impact Sponsor. This collaboration marks a significant milestone in FPN’s mission to advance patient education for individuals affected by peripheral neuropathy (PN). Collaboration for Impact At FPN, our commitment to improving the lives of those living […]
The Foundation for Peripheral Neuropathy (FPN) is excited to share that The Ohio State University (OSU) has joined the IMAGiNe Study as a new research site. With help from FPN, OSU will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare and often misunderstood nerve disease. About the IMAGiNe Study The […]
Read More… from FPN welcomes The Ohio State University as a new site for the IMAGiNe Study
10 marathons. 26.2 miles. 1 mission. Please join us in celebrating PN patient and FPN friend Dieter’s incredible journey running Chicago 10 times! Now with a new purpose: raising awareness and funds for peripheral neuropathy. Diagnosed with idiopathic polyneuropathy in 2024, Dieter continues to run strong, proving that resilience and advocacy go hand in hand. Join […]